Itron (ITRI) to Release Earnings on Tuesday

Itron (NASDAQ:ITRI) is expected to announce its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect Itron to post earnings of $1.31 per share and revenue of $566.34 million for the quarter. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Tuesday, July 28, 2026 at 10:00 AM ET.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. The company had revenue of $586.98 million during the quarter, compared to the consensus estimate of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. Itron’s revenue was down 3.3% on a year-over-year basis. During the same period in the prior year, the company earned $1.52 EPS. On average, analysts expect Itron to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Itron Stock Performance

Shares of ITRI opened at $84.22 on Monday. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24. The firm’s 50 day moving average is $82.96 and its 200-day moving average is $89.82. Itron has a 12-month low of $77.77 and a 12-month high of $142.00. The stock has a market capitalization of $3.73 billion, a P/E ratio of 13.43, a P/E/G ratio of 0.74 and a beta of 1.32.

Analyst Ratings Changes

Several research analysts have issued reports on ITRI shares. JPMorgan Chase & Co. decreased their price target on shares of Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Zacks Research downgraded Itron from a “hold” rating to a “strong sell” rating in a research report on Friday, July 17th. Weiss Ratings reissued a “hold (c)” rating on shares of Itron in a research note on Friday, May 8th. Raymond James Financial assumed coverage on Itron in a report on Tuesday, April 21st. They issued an “underperform” rating on the stock. Finally, Oppenheimer boosted their target price on Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research report on Thursday, April 16th. Eight analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Itron has an average rating of “Hold” and a consensus target price of $131.22.

Insider Activity at Itron

In other Itron news, SVP John F. Marcolini sold 322 shares of Itron stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total transaction of $27,167.14. Following the transaction, the senior vice president directly owned 24,689 shares in the company, valued at approximately $2,083,010.93. The trade was a 1.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Joan S. Hooper sold 442 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total transaction of $37,291.54. Following the sale, the chief financial officer directly owned 117,478 shares in the company, valued at approximately $9,911,618.86. This trade represents a 0.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 3,946 shares of company stock worth $324,420. 1.77% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Itron

Several institutional investors and hedge funds have recently bought and sold shares of the business. Employees Retirement System of Texas purchased a new stake in shares of Itron in the third quarter worth approximately $32,000. Northwestern Mutual Wealth Management Co. grew its position in Itron by 29.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after purchasing an additional 101 shares in the last quarter. Advisory Services Network LLC acquired a new position in Itron in the 3rd quarter valued at approximately $49,000. EverSource Wealth Advisors LLC increased its stake in Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after buying an additional 81 shares during the period. Finally, UMB Bank n.a. lifted its position in Itron by 271.6% in the 4th quarter. UMB Bank n.a. now owns 732 shares of the scientific and technical instruments company’s stock worth $68,000 after buying an additional 535 shares in the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.